NCT00103818View on ClinicalTrials.gov

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

900

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

October 31, 2006

Conditions

Insomnia

Interventions

DRUG

gaboxadol

Duration of Treatment: 3 months

DRUG

Comparator: placebo (unspecified)

Duration of Treatment: 3 months

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY